Bizarre patent tussles over a COVID-19 jab

Moderna’s many intellectual property disputes over its vaccine highlight the need for a patent-free regime to fight the pandemic

In the midst of war, Russia hits at patents

As US-EU sanctions deepen, Moscow passes a law to allow free use of patents owned by ‘unfriendly countries’

Historic win for farmer seed rights: PepsiCo’s IPR on potato variety revoked

Judgement against Pepsico potato variety sets precedent for all seed and food and beverages corporations not to transgress farmers’ seed …

It will be months before there is consensus over COVID-19 vaccine patents: Experts

The United States has supported a temporary waiver on COVID-19 vaccine patents; but not all is hunky-dory, say experts

Road to COP15 Montreal: Mexican indigenous groups yet to benefit under Nagoya Protocol; here is why

The Convention on Biological Diversity leaves many matters to the interpretation of each country’s laws

Let it flow: COVID-19 pandemic underscores need to share research; but how will it work

The scientific community has rolled out plans to remove hurdles in the shift to open access publishing. Will this ensure equitable access?

Only a piglet in Russia’s war on patents

Post-Ukraine, Russia has held back from appropriating intellectual property despite a law to punish unfriendly countries

A dirty US fight to control WIPO

China loses to Singapore in American smear campaign but the US will have to contend with an IP powerhouse

Can vaccines become as cheap as generics?

Unlike with drugs, freeing up patents will not make it any easier to manufacture vaccines for COVID-19, says Cipla’s Hamied

Coronavirus vaccines: Tech transfer is the new mantra

A tech transfer hub for mRNA vaccines is being set up in South Africa, a first for the continent; but will the pharmaceutical companies play ball?

TRIPS waiver for COVID-19 vaccines, meds just got tougher after US support

Biden administration wants text-based negotiations on a waiver limited to vaccines but no one is complaining   

Don’t worry, experts say after Pakistan gets GI tag for its own Basmati rice

Basmati joint heritage of the subcontinent; Pakistan’s exports will not dent India's share

‘Compromise’ on TRIPS waiver is a sellout

Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers to production of COVID-19 medical tools

The curious case of Covaxin royalties

ICMR’s contradictions and obfuscation on ownership of the vaccine’s intellectual property is not helping in the fight against COVID-…

COVID-19 Challenge 2021: How does the world overcome vaccine shortage

The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …

Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth

Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …

Post-pandemic blues of predatory pharma

Huge stockpiles of COVID-19 vaccines and treatments, along with a steep drop in revenues, tell a sorry tale of Big Pharma’s greed   

Follow the Chinese way on high tech

Making universities the hub of innovation and churning out scientists adept in frontier technology has put China at the top

Untapped potential

India’s two-decade journey with Geographical Indication tags has shown limited out-come and there is an urgent need to simplify the …

WTO decision on access to COVID-19 drugs without strings delayed

Proposal will be formally discussed in March next year, sources say